PTC Therapeutics (PTCT) PT Raised to $90 at UBS

October 15, 2026 9:17 AM

UBS analyst Joon Lee raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $90.00 (from $80.00) while maintaining a Buy rating.

No results found